Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

Greece introduced a 13-valent pneumococcal conjugate vaccine (PCV13) into the infant national immunization program in 2010 (3 + 1 schedule until June 2019). Since 2015, PCV13 has been recommended for adults aged 19–64 years with comorbidities and adults ≥65 years sequentially with 23-valent pneumoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Liapikou, Adamantia, Konstantinidis, Athanasios, Kossyvaki, Vasiliki, Skiadas, John, Menegas, Damianos, Méndez, Cristina, Beavon, Rohini, Begier, Elizabeth, Gessner, Bradford D., Milionis, Haralampos, Tsimihodimos, Vasilios, Baxevanos, Gerasimos, Argiriadou, Theodora, Terrovitou, Chrysavgi, Toumbis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Pneumococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621052/
https://www.ncbi.nlm.nih.gov/pubmed/35703733
http://dx.doi.org/10.1080/21645515.2022.2079923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621052/
https://www.ncbi.nlm.nih.gov/pubmed/35703733
http://dx.doi.org/10.1080/21645515.2022.2079923

Ejemplares similares